Characterization of alpha-difluoromethylornithine resistant Leishmania donovani and its susceptibility to other inhibitors of the polyamine biosynthetic pathway

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
R MukhopadhyayR Madhubala

Abstract

The promastigote form of Leishmania donovani is sensitive to growth inhibition by DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, exhibiting an IC50 of 125 microM. Exposure of a wild type cell population to gradually increasing concentrations of DL-alpha-difluoromethylornithine resulted in the selection of a strain of Leishmania, which was capable of proliferating in 5 mM DFMO with an IC50 value of 10 mM. This resistant strain showed increased ornithine decarboxylase activity and higher levels of putrescine. It was sensitive to growth inhibition by bis (benzyl) analogs of spermine and a potent S-adenosylmethionine decarboxylase inhibitor, CGP 40215A. These results indicate the potential value of other inhibitors of the polyamine biosynthetic pathway as therapeutic agents in conditions where ODC inhibitors are ineffective.

Citations

May 4, 2011·Infection and Immunity·Caslin GilroyBuddy Ullman
Feb 13, 2010·Molecular Microbiology·Marie-Pierre HasneBuddy Ullman
Jun 1, 2010·Amino Acids·Gianni Colotti, Andrea Ilari
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·B PapadopoulouM Ouellette

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.